Hunan Jingfeng Pharmaceutical Co.,Ltd. (SHE:000908)

SHE:000908 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 14, 2026	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	12,510	4,302	2,850	2,798	3,836	3,994
Market Cap Growth	252.85%	50.93%	1.89%	-27.06%	-3.96%	19.79%
Enterprise Value	12,688	4,767	3,316	3,367	5,039	5,203
Last Close Price	7.11	4.89	3.24	3.18	4.36	4.54
PE Ratio	39.94	28.25	-	-	-	-
PS Ratio	31.82	10.34	4.34	3.33	4.73	4.55
PB Ratio	-331.36	-284.36	-16.32	13.88	11.70	6.26
P/TBV Ratio	-	152.38	-	92.95	22.19	11.30
P/FCF Ratio	41144.62	-	115.67	25.49	44.75	-
P/OCF Ratio	7019.22	-	81.29	22.70	30.98	-
EV/Sales Ratio	32.27	11.46	5.05	4.01	6.21	5.93
EV/EBITDA Ratio	-	230.72	-	104.46	-	-
EV/FCF Ratio	41728.63	-	134.56	30.68	58.79	-
Debt / Equity Ratio	-7.38	-31.11	-3.40	2.97	2.67	2.08
Debt / EBITDA Ratio	556.54	20.42	-	16.65	-	-
Debt / FCF Ratio	916.83	-	24.10	5.46	10.19	-
Net Debt / Equity Ratio	-6.69	-25.46	-3.32	2.07	2.14	1.82
Net Debt / EBITDA Ratio	-133.48	18.64	-8.88	12.95	-3.30	-1.88
Net Debt / FCF Ratio	830.85	-55.57	23.56	3.80	8.18	-3.16
Asset Turnover	0.41	0.42	0.52	0.52	0.36	0.25
Inventory Turnover	2.54	2.85	2.14	1.49	1.67	1.18
Quick Ratio	0.30	0.19	0.13	0.37	0.35	0.38
Current Ratio	0.39	0.25	0.21	0.53	0.50	0.55
Return on Equity (ROE)	-	-	-1685.13%	-35.99%	-41.75%	-89.70%
Return on Assets (ROA)	-1.19%	-0.33%	-5.18%	-0.75%	-8.64%	-12.41%
Return on Invested Capital (ROIC)	-5.92%	-1.33%	-20.36%	-2.36%	-21.89%	-29.36%
Return on Capital Employed (ROCE)	-20.10%	-15.10%	-555.10%	-5.20%	-71.80%	-84.10%
Earnings Yield	1.25%	3.54%	-8.28%	-4.38%	-4.27%	-26.75%
FCF Yield	0.00%	-0.16%	0.86%	3.92%	2.23%	-9.21%
Payout Ratio	8.58%	8.80%	-	-	-	-
Buyback Yield / Dilution	-0.01%	-0.02%	0.02%	0.01%	0.36%	-0.03%
Total Shareholder Return	-0.01%	-0.02%	0.02%	0.01%	0.36%	-0.03%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.